- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 11/00 - Drugs for disorders of the respiratory system
Patent holdings for IPC class A61P 11/00
Total number of patents in this class: 11188
10-year publication summary
|
257
|
244
|
475
|
501
|
592
|
1004
|
883
|
1077
|
750
|
687
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
289 |
| Chiesi Farmaceutici S.p.A. | 973 |
176 |
| Boehringer Ingelheim International GmbH | 4635 |
154 |
| AstraZeneca AB | 2858 |
140 |
| Vertex Pharmaceuticals Incorporated | 1628 |
118 |
| Novartis AG | 10623 |
111 |
| Daiichi Sankyo Company, Limited | 1877 |
71 |
| F. Hoffmann-La Roche AG | 7933 |
64 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3373 |
63 |
| Genentech, Inc. | 4015 |
56 |
| Bristol-myers Squibb Company | 4820 |
54 |
| Takeda Pharmaceutical Company Limited | 2717 |
54 |
| The Regents of the University of California | 20289 |
51 |
| Glaxosmithkline Intellectual Property Development Limited | 779 |
51 |
| Bayer AG | 3395 |
47 |
| Bayer Pharma AG | 1048 |
45 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3210 |
44 |
| Theravance Biopharma R&D IP, LLC | 453 |
43 |
| Centre National de La Recherche Scientifique | 10693 |
39 |
| Board of Regents, The University of Texas System | 5938 |
38 |
| Other owners | 9480 |